Shares of Intuitive Surgical (NSDQ:ISRG) jumped nearly 5% in after-hours trading today on 2nd-quarter results that handily beat expectations on Wall Street.
The Sunnyvale, Calif.-based robot-assisted surgery device maker reported profits of $134.5 million, or $3.56 per share, on sales of $586.1 million for the 3 months ended June 30, representing a 29.3% bottom-line gain on sales growth of 14.4% compared with Q2 2014.
Adjusted to exclude 1-time items, earnings per share were $4.57, a full 59¢ ahead of expectations on Wall Street.
“We are pleased with our 2nd-quarter procedure growth and financial results. We remain focused on supporting our customers in their mission of bringing high value care to patients,” president & CEO Gary Guthart said in prepared remarks.
ISRG shares rose 4.9% to $530.25 apiece in after-hours trading today.
Intuitive also said that it won 510(k) clearance from the FDA during the quarter for additions to the instruments available for use with its da Vinci Xi device, including the Harmonic Ace curved shears made by Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon.
Across the pond, Intuitive won CE Mark approval in the European Union for an integrated table motion product for the da Vinci Xi platform, saying it’s already filed for a 510(k) for the device in the U.S.
The post Intuitive Surgical shares jump after hours on Street-beating Q2 appeared first on MassDevice.
from MassDevice http://ift.tt/1SAiI9S
Cap comentari:
Publica un comentari a l'entrada